Paul Parker

Paul Parker

Director/Board Member at GENERATE BIOMEDICINES, INC.

Net worth: - $ as of 2026-06-29

63 year
Finance
Consumer Services
Health Technology

Profile

Paul G.
Parker
is currently Non-Executive Director at Generate Biomedicines, Inc. since 2025 and Managing Partner at Flagship Pioneering, Inc. since 2024.
Former roles include Independent Director at The Clorox Co. from 2020 to 2024, Senior VP-Strategy & Corporate Development at Thermo Fisher Scientific, Inc. from 2020 to 2024, Co-Chairman-Global Mergers & Acquisitions Group at The Goldman Sachs Group, Inc. from 2014 to 2020, Chairman, Head-Global Mergers & Acquisitions at Barclays PLC from 2008 to 2014, Head-Global Mergers & Acquisitions at Lehman Brothers Holdings, Inc. in 2008, and Director at New York City Outward Bound, Inc. Education includes an undergraduate degree from The University of North Carolina at Chapel Hill in 1985 and an MBA from Harvard Business School in 1990.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-02-26 0 ( -.--% ) - $ 2026-06-29

Paul Parker active positions

CompaniesPositionStart
GENERATE BIOMEDICINES, INC. Director/Board Member 2025-05-31
Private Equity Investor 2024-08-31

Former positions of Paul Parker

CompaniesPositionEnd
THE CLOROX COMPANY Director/Board Member 2024-11-19
THERMO FISHER SCIENTIFIC, INC. Corporate Officer/Principal 2024-07-31
THE GOLDMAN SACHS GROUP, INC. Corporate Officer/Principal 2020-02-29
BARCLAYS PLC Chairman 2014-06-30
Corporate Officer/Principal 2008-08-31
See the detail of Paul Parker's experience

Training of Paul Parker

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

93

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Consumer Non-Durables

Finance

Finance

Finance

Finance

Consumer Services

Health Technology

Commercial Services

Consumer Services

Health Technology